Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study
Recruiting · NCT07380737 · Interventional (participants receive a specific treatment) · Lead sponsor: Tel-Aviv Sourasky Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
Walking Tall App
What this trial is about
This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.
Who can take part
Age range
40 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
- Hoehn \& Yahr stage II-III (ON-medication state);
- Able to walk independently for ≥5 minutes;
- Stable medication for ≥1 month;
- Currently enrolled in a rehab program at Ezra LeMarpe;
- Able to provide written informed consent;
Exclusion criteria
- Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
- Cognitive impairments or severe behavioral symptoms;
- History of stroke, severe TBI, or brain tumor;
- Cardiovascular contraindications;
- Inability to use a smartphone;
- Participation in other concurrent intervention studies.
Where it is running
1 location listed.
- Tel Aviv Sourasky Medical Center (Ichilov Hospital) - Tel Aviv, Israel